<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Vaginal-Microbiome-Lbp on Bioecon</title><link>https://en.bioecon.ru/technologies/vaginal-microbiome-lbp/</link><description>Recent content in Vaginal-Microbiome-Lbp on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 28 Jun 2026 11:23:52 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/vaginal-microbiome-lbp/index.xml" rel="self" type="application/rss+xml"/><item><title>FemTech biotech &amp; women's health</title><link>https://en.bioecon.ru/technology/femtech-biotech-womens-health/</link><pubDate>Sun, 28 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/femtech-biotech-womens-health/</guid><description>Specialized biologic, diagnostic and live-biotherapeutic products for conditions that affect exclusively or disproportionately women — non-invasive endometriosis testing, ovarian-longevity therapeutics, vaginal-microbiome LBPs and cfDNA prenatal screening, under FDA, EU IVDR/EMA and NMPA oversight.</description></item></channel></rss>